A physician-guided framework for deciding what should be evaluated before treatment and what may need follow-up.
Symptoms such as fatigue, changes in body composition, reduced exercise tolerance, sleep problems or difficulty losing weight can have many causes. A medical evaluation helps determine whether concerns may relate to nutrition, medications, sleep disorders, thyroid disease, metabolic disease, hormone abnormalities or other conditions that require a different approach.
The visit may include review of medical history, medications and supplements, prior treatment, weight trajectory, nutrition, exercise, sleep, symptoms, family history, contraindications and the patient’s goals. When clinically appropriate, laboratory testing may be ordered to evaluate relevant medical conditions or establish a baseline before treatment.
There is no single universal “peptide panel.” Appropriate testing depends on the treatment being considered, the patient’s history and the clinical question. Depending on the situation, a physician may consider metabolic markers, glucose-related testing, thyroid function, liver and kidney function, blood counts, nutritional markers, hormone testing or other studies. Testing should be targeted rather than ordered simply because a patient is interested in a peptide.
Follow-up should assess treatment response, side effects, adherence, changes in symptoms, weight or body composition when relevant, and any laboratory monitoring appropriate to the specific therapy. Some therapies require more structured monitoring than others. If the evidence base is limited or the product is unapproved, that uncertainty should be part of the risk-benefit discussion.
FDA states that compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness or quality. FDA has also identified potential safety concerns and limited human data for several peptide substances promoted by some clinics, including BPC-157 and ipamorelin. Review our Peptide Therapy Evidence & Regulatory Status Guide and Peptide Therapy Safety & Side Effects page.
Explore What Are Peptides?, Growth Hormone-Releasing Peptides Explained, BPC-157 Safety & Evidence, and Peptide Therapy vs GLP-1 Medications.
The comprehensive initial physician evaluation is $450 and is designed to establish care, review contributing medical factors and determine whether diagnostic testing or treatment is clinically appropriate. Follow-up physician visits are $250 and may include review of laboratory results, response, side effects and treatment adjustments when medically appropriate.
Board Certified in Internal Medicine. This content is educational and does not replace individualized medical care. Photo: Accuray / Unsplash.
